Skip to main content
Fig. 2 | Advances in Rheumatology

Fig. 2

From: Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Fig. 2

Treatments utilized by Latin American patients with SpA. Source data for this figure can be found in Supplementary Table 3. ADL, adalimumab; CS, corticosteroids; CTZ, certolizumab pegol; DMARDs; disease-modifying anti-rheumatic drugs; ETN; etanercept; EU, European Union; GOL, golimumab; INF, infliximab; LEF, leflunomide; MTX, methotrexate; NSAIDs, non-steroidal anti-inflammatory drugs; PA, pamidronic acid; SSZ, sulfasalazine; TNFi, tumor necrosis factor inhibitor

Back to article page

Advances in Rheumatology

ISSN: 2523-3106